Boston Therapeutics, Inc. — Form D/A
Boston Therapeutics, Inc. of LAWRENCE, MA, a company, filed a Form D amendment with the SEC on 2016-09-20. The offering totals $2.0M, of which $1.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-09-20
- Form: D/A
- Accession: 0001102624-16-003396
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.6M
- Remaining: $400K
- Minimum investment: $25K
- Investors: 28
- Date of first sale: 2016-08-12
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-269587
Issuer
- Name: Boston Therapeutics, Inc.
- CIK: 0001473579
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 354 MERRIMACK STREET #4, LAWRENCE, MA, 01843
- Phone: 603-935-9799
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Rom W Eliaz | Director | Lawrence, MA |
| Alan W Hoberman | Director | Lawrence, MA |
| Colin W Neill | Director | Lawrence, MA |
| Carl W Rausch | Executive Officer | Lawrence, MA |
| David Platt | Director | Atglen, PA |
| David Platt | Executive Officer | Atglen, PA |
| Conroy Chi-Heng Cheng | Director | Lawrence, MA |
| David Ludvigson | Director | Lawrence, MA |
| David Ludvigson | Executive Officer | Lawrence, MA |
| Dale H Conaway | Director | Newton, MA |
| Henry W Esber | Director | Manchester, NH |
| Dale W Conway | Director | Manchester, NH |
| Rom H Eliaz | Director | Manchester, NH |
| Carl H Lueders | Director | Manchester, NH |
| Henry H Esber | Director | Manchester, NH |
| Kenneth Tassey, Jr. | Director | Manchester, NH |
| Kenneth Tassey, Jr. | Executive Officer | Manchester, NH |
| Kenneth Tassey, Jr. | Promoter | Manchester, NH |
| David Platt, Ph. D. | Director | Manchester, NH |
| David Platt, Ph. D. | Executive Officer | Manchester, NH |
| David Platt, Ph. D. | Promoter | Manchester, NH |
| Kenneth A Tassey, Jr. | Director | Manchester, NH |
| Kenneth A Tassey, Jr. | Executive Officer | Manchester, NH |
Other filings by this issuer (4)
More